Percutaneous Bleomycin Sclerotherapy for Retroorbital Venous Malformations
CardioVascular and Interventional Radiology · 29.07.2026 · 49 (11) · 2484-2487
DOI: 10.1007/s00270-026-04541-0 ↗Kurz gefasst
Leserbrief in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 29.07.2026. Verfasst von Harrison Blume und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lenox Hill Hospital, New York, NY, 10075, USA. hblume@northwell.edu. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Society of Interventional Radiology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lenox Hill Hospital, New York, NY, 10075, USA. hblume@northwell.edu.
- School of Medicine, Johns Hopkins University, Baltimore, MD, 21287, USA.
- Russell H. Morgan Department of Radiology and Radiological Science, Division of Interventional Radiology, Johns Hopkins Hospital, 7203 Sheikh Zayed Tower, Suite 7, 1800 Orleans Street, Baltimore, MD, 21287, USA.
Förderung
- Society of Interventional Radiology
Zitieren
APA
Blume, H., Kim, A. J., Khan, M. A., & Weiss, C. R. (2026). Percutaneous Bleomycin Sclerotherapy for Retroorbital Venous Malformations. CardioVascular and Interventional Radiology, 49(11), 2484-2487. https://doi.org/10.1007/s00270-026-04541-0
Vancouver
Blume H, Kim AJ, Khan MA, Weiss CR. Percutaneous Bleomycin Sclerotherapy for Retroorbital Venous Malformations. CardioVascular and Interventional Radiology. 2026;49(11):2484-2487. doi:10.1007/s00270-026-04541-0
BibTeX
@article{Blume2026,
author = {Blume, Harrison and Kim, Alan J and Khan, Majid A and Weiss, Clifford R},
title = {Percutaneous Bleomycin Sclerotherapy for Retroorbital Venous Malformations},
journal = {CardioVascular and Interventional Radiology},
year = {2026},
volume = {49},
number = {11},
pages = {2484--2487},
doi = {10.1007/s00270-026-04541-0}
}
EUVIMED